Podrobný výpis o publikaci

@proceedings{53777,
   author = {Radvan, Martin and Kameník, Martin and Koc, Lumír and Matejová, Gabriela and Bartečková, Eliška and Hořínková, Jana and Štěpánová, Radka and Kala, Petr},
   booktitle = {ESC Congress 2022 - Barcelona, Spain 26–29 August 2022},
   title = {No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers},
   url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619562/pdf/ehac544.1540.pdf},
   year = {2022}
}

TY  - CONF
ID  - 53777
AU  - Radvan, Martin - Kameník, Martin - Koc, Lumír - Matejová, Gabriela - Bartečková, Eliška - Hořínková, Jana - Štěpánová, Radka - Kala, Petr
PY  - 2022
TI  - No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619562/pdf/ehac544.1540.pdf
N2  - lt;0.001) between V1 a V3, a mild enlargement of left atrium (37.1±5.85 to 38.2±5.65mm; p=0,021) and nonsignificant trend to impairment of left ventricle diastolic dysfunction. There was a mild change of pulmonary artery systolic pressure (24.7±7.92 to 27.5±6.97mmHg; p=0,038). Conclusion: Despite many information regarding cardiac impairment of SARS-CoV-2 our study does not suggest increased risk of development of heart failure during the one year follow-up. Based on our results the routine echocardiography and biomarkers collection is currently not recommended after COVID-19 recovery.
ER  - 

RADVAN, Martin, Martin KAMENÍK, Lumír KOC, Gabriela MATEJOVÁ, Eliška BARTEČKOVÁ, Jana HOŘÍNKOVÁ, Radka ŠTĚPÁNOVÁ a Petr KALA. No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers. In \textit{ESC Congress 2022 - Barcelona, Spain 26–29 August 2022}. 2022.